New cancer drug GEN1056 tested in humans for first time
Disease control
Completed
This early-stage trial tested a new drug called GEN1056 in 26 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and find the best dose. Researchers also looked for any signs that the drug might shrin…
Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control
Last updated May 17, 2026 02:38 UTC